Safety Alert for DePuy ADEPT 12/14 Modular Head

According to Department of Health, this safety alert involved a device in Hong Kong that was produced by DePuyOrthopaedics.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2013-01-22
  • Event Date Posted
    2013-01-22
  • Event Country
  • Event Source
    DH
  • Event Source URL
  • Notes / Alerts
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Extra notes in the data
    Medical Device Safety Alert
  • Reason
    Medical device safety alert: depuy adept 12/14 modular head the medicines and healthcare products regulatory agency (mhra), united kingdom posted a medical device safety alert concerning adept 12/14 modular head, manufactured bydepuyorthopaedics(a johnson & johnson company). review of post‐market surveillance data suggests a higher than expected revision rate for the adept 12/14 modular head when used in conventional total hip arthroplasty. analysis of uk national joint registry supplier feedback data indicates a cumulative revision rate of 12.1% (95% ci 9.5% to 15.4%) at 7 years for the affected product when used in conventional total hip arthroplasty. in september 2012, the australian orthopaedic association national joint replacement registry reported a cumulative revision rate of 7.1% (95% ci 3.6% to 13.6%) at 3 years with 8 revisions in a cohort of 121 adept 12/14 modular head cases used in conventional total hip arthroplasty. the manufacturer advises that patients who have received the affected products should be followed according to local guidance/standard of care for patients receiving metal on metal (mom) articulations. also, refer to the local orthopaedic association for detailed information related to the treatment of patients with mom articulations. for details, please refer to mhra website: http://www.Mhra.Gov.Uk/safetyinformation/safetywarningsalertsandrecalls/ fieldsafetynotices/con224428 if you are in possession of the affected product, please contact your supplier for necessary actions. posted on 22 january 2013.

Device

  • Model / Serial
  • Product Description
    Medical Device Safety Alert: DePuy ADEPT 12/14 Modular Head
  • Manufacturer

Manufacturer